Neurotech Director Departs With Related Entity Holding 4.6 Million Shares
NTI: $0.016 -5.88% · MC: $31M
Robert Maxwell Johnston ceased to be a director of Neurotech International Limited on 5 November; his final interest notice records 4.6 million ordinary shares held by a related entity. The company’s recent quarterly update said it expected to be funded through the top-line readout of its Phase 3 autism trial, which has begun dosing.

Comments